LDR | |
01249nam a2200337 a 4500 |
001 |
|
002586389 |
003 |
|
MiAaHDL |
005 |
|
20220616000000.0 |
006 |
|
m d |
007 |
|
cr bn ---auaua |
008 |
|
921217s1992 nyua b 001 0 eng d |
020 |
⊔ |
⊔ |
‡a0881679224
|
035 |
⊔ |
⊔ |
‡a(MiU)990025863890106381
|
035 |
⊔ |
⊔ |
‡asdr-miu.990025863890106381
|
035 |
⊔ |
⊔ |
‡z(MiU)MIU01000000000000002586389-goog
|
035 |
⊔ |
⊔ |
‡a(OCoLC)28427286
|
035 |
⊔ |
⊔ |
‡z(MiU)Aleph002586389
|
040 |
⊔ |
⊔ |
‡aMOP
‡cMOP
‡dMDU
‡dVET
‡dEYM
|
090 |
⊔ |
⊔ |
‡aRC375
‡b.T645 1992
|
096 |
⊔ |
⊔ |
‡aWM 197 T727 1992
|
245 |
0 |
0 |
‡aTourette Syndrome :
‡bgenetics, neurobiology, and treatment /
‡ceditors Thomas N. Chase, Arnold J. Friedhoff, Donald J. Cohen.
|
260 |
⊔ |
⊔ |
‡aNew York :
‡bRaven Press,
‡cc1992.
|
300 |
⊔ |
⊔ |
‡axix, 377 p. :
‡bill. ;
‡c27 cm.
|
490 |
0 |
⊔ |
‡aAdvances in neurology ;
‡vv. 58
|
500 |
⊔ |
⊔ |
‡aDrug therapy sections : p. 241-291.
|
504 |
⊔ |
⊔ |
‡aIncludes bibliographical references and index.
|
538 |
⊔ |
⊔ |
‡aMode of access: Internet.
|
650 |
⊔ |
2 |
‡aTourette Syndrome
‡xdrug therapy.
|
650 |
⊔ |
2 |
‡aTourette Syndrome.
|
650 |
⊔ |
0 |
‡aTourette syndrome
|
700 |
1 |
⊔ |
‡aCohen, Donald J.
|
700 |
1 |
⊔ |
‡aFriedhoff, Arnold J.,
‡d1923-
|
700 |
1 |
⊔ |
‡aChase, Thomas N.
‡q(Thomas Newell),
‡d1932.
|
899 |
⊔ |
⊔ |
‡a39015028454349
|
CID |
⊔ |
⊔ |
‡a002586389
|
DAT |
0 |
⊔ |
‡a20220615073816.0
‡b20220616000000.0
|
DAT |
1 |
⊔ |
‡a20220616060654.0
‡b2023-06-24T17:49:38Z
|
CAT |
⊔ |
⊔ |
‡aSDR-MIU
‡dALMA
‡lprepare.pl-004-008
|
FMT |
⊔ |
⊔ |
‡aBK
|
HOL |
⊔ |
⊔ |
‡0sdr-miu.990025863890106381
‡aMiU
‡bSDR
‡cMIU
‡pmdp.39015028454349
‡sMIU
‡1990025863890106381
|
974 |
⊔ |
⊔ |
‡bMIU
‡cMIU
‡d20230624
‡sgoogle
‡umdp.39015028454349
‡y1992
‡ric
‡qbib
‡tUS bib date1 >= 1930
|